$36.090
-0.090 (-0.25%)At close
WAFD News
WAFD Events
WaFd Reports 15% Year-over-Year EPS Growth in Q3
"WaFd delivered strong results in the third quarter of fiscal 2026, with healthy growth in earnings, loans, and equity," said president and CEO Brent Beardall. "Earnings per share increased 15% year-over-year and 2% compared to the March quarter. While overall loans outstanding grew modestly for the quarter, net loans in our active loan portfolios grew at an annualized rate of 10.4%. Growth in net interest income, combined with disciplined expense management, drove our efficiency ratio to 53.7%, and we delivered an 11.0% return on tangible common equity for the quarter. We believe that the market is beginning to recognize WaFd's consistent earnings power - our stock price is up 19% from March 31, with 4.7 million shares repurchased in the first two quarter of the fiscal year. I want to thank our team of bankers for their continued dedication to delivering for our clients and shareholders."
CEO: Despite Uncertainty, Q2 Revenue Reaches $197.4 Million
Reports Q2 revenue $197.4M, consensus $190.5M. CEO Brent Beardall states: "Uncertainty seems to be our new reality, not just in the banking sector, but also in the broader global context. Our strong foundation enabled us to deliver for our customers even during uncertain times. During the quarter, we executed on our strategic plan and grew our active loan segments by 12% annualized. Given our growth in loans, notable improvements in asset quality metrics, and a widening margin, we see a bright future in spite of current uncertainties. Our stock was trading near tangible book value for the majority of the quarter, so we aggressively bought back shares at less than 1.1x tangible book value. We were able to buy back 3.6% of total outstanding shares during the quarter. Our return on tangible common equity was 10.8% making it one of the best investment alternatives available to us. Credit goes to our amazing team of bankers that is working hard to deliver for our clients."
WaFd Increases Share Repurchase Authorization to 10 Million Shares
The Board of Directors of WaFd increased the number of shares authorized for repurchase by 4.5M, bringing the currently authorized amount up to 10M shares. Over the last seven quarters the Company has repurchased 5.8M shares at a weighted average price of $29.45, this represents 7% of the shares outstanding on March 31, 2024. WaFd, Inc. is the parent company of WaFd Bank.
S&P 500 Dips to 6940.01 Amid Mixed Earnings
The major averages had a tepid session, all closing fractionally lower, with the S&P 500 nearing the 7,000 mark and the Dow remaining close to the 50,000 level. Bank earnings kicked off with a mixed week, and strength in semiconductors hasn't completely pushed back concerns around mixed macro signals.Looking to commodities, oil prices eased after the chance of a U.S. strike on Iran receded, tempering energy sector pressure, while gold dipped on stronger U.S. data boosting the dollar and reducing near-term rate-cut bets.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Vistraand Constellation Energywere slipping after the White House reached an agreement with a number of U.S. states to curb electricity costs,PNC Financialreportedand provided guidance for Q1 and FY26Regions Financialreported downbeat, with Wells Fargo downgrading the stockJ.B. Huntreported, saying the "freight market feels fragile" entering 2026Drugmakers are concerned about legal risk with the FDA's expedited review program,2. WALL STREET CALLS:BioNTechto Buy at Goldman Sachs on cancer potentialSusquehannaSeagateto Neutral on HDD industry growthKraft Heinzto Underweight at Morgan StanleyTractor Supplyto Hold at TruistHP Inc.to Underweight at Barclays3. AROUND THE WEB:The U.S. Supreme Court will hear Bayer'sappeal of Roundup lawsuitst, Bloomberg reportsBeyond Meatis testing a line of protein drinks, WSJ reportsThe European Patent Office appeals board has revoked one of Arbutus Biopharma'spatents, which is likely to affect its case against Modernain Switzerland and one Unified Patent Court case, Bloomberg saysAlibabaplans to link its online shopping and travel services to its AI app, Qwen, to build it into a one-stop artificial intelligence platform for consumers, Bloomberg saysThe proposed merger between Rio Tintoand Glencoremay require asset sales to win approval from China, which has concerns about resource security and market concentration, Reuters says4. MOVERS:ImmunityBiohigher after announcingfrom its ongoing QUILT-206 studyAST SpaceMobileincreases after beingby Missile Defense AgencyRiot Platformsgains after announcing a land acquisition andwith AMDSasollower after in New York JPMorganthe stock to UnderweightEndeavour Silverfalls in New York after providing5. EARNINGS/GUIDANCEOndasprovidedand raised its outlook for FY26WaFd, with revenue missing consensusWipro, with CEO Srini Pallia commenting, "In Q3, we delivered broad based growth in line with our expectations"QXOreportedState Street, with EPS and revenue beating consensusINDEXES:The Dow fell 83.11, or 0.17%, to 49,359.33, the Nasdaq lost 14.63, or 0.062%, to 23,515.39, and the S&P 500 declined 4.46, or 0.064%, to 6,940.01.
S&P 500 Nears 7,000 Amid Market Volatility
The major averages were mostly unchanged near noon following yesterday's rally as the S&P 500 reaches for 7,000. Bank earnings have had a mixed week, and strength in semiconductors hasn't completely pushed back concerns around mixed macro signals.Looking to commodities, oil prices have eased after the chance of a U.S. strike on Iran receded, tempering energy sector pressure, while gold dipped on stronger U.S. data boosting the dollar and reducing near-term rate-cut bets.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Vistraand Constellation Energywere slipping after the White House reached an agreement with a number of U.S. states to curb electricity costs,PNC Financialreportedand provided guidance for Q1 and FY26Regions Financialreported, with Wells Fargo downgrading the stockJ.B. Huntreported, saying the "freight market feels fragile" entering 2026Drugmakers are concerned about legal risk with the FDA's expedited review program,2. WALL STREET CALLS:BioNTechto Buy at Goldman Sachs on cancer potentialSusquehannaSeagateto Neutral on HDD industry growthKraft Heinzto Underweight at Morgan StanleyTractor Supplyto Hold at TruistHP Inc.to Underweight at Barclays3. AROUND THE WEB:The European Patent Office appeals board has revoked one of Arbutus Biopharma'spatents, which is likely to affect its case against Modernain Switzerland and one Unified Patent Court case, Bloomberg saysHersheyhas increased its marketing budget for the Hershey's brand by 20% to launch its first new advertising campaign in eight years, with the new strategy including influencer campaigns on TikTok and live events, WSJ reportsAlibabaplans to link its online shopping and travel services to its AI app, Qwen, to build it into a one-stop artificial intelligence platform for consumers, Bloomberg saysThe BBC plans to produce programs for Google'sYouTube for the first time, FT reportsThe proposed merger between Rio Tintoand Glencoremay require asset sales to win approval from China, which has concerns about resource security and market concentration, Reuters says4. MOVERS:ImmunityBiohigher after announcingfrom its ongoing QUILT-206 studyAST SpaceMobileincreases after beingby Missile Defense AgencyRiot Platformsgains after announcing a land acquisition and data center(AMD)Sasollower after in New York JPMorganthe stock to UnderweightEndeavour Silverfalls in New York after5. EARNINGS/GUIDANCEOndasand raised its outlook for FY26WaFd, with revenue missing consensusWipro, with CEO Srini Pallia commenting, "In Q3, we delivered broad based growth in line with our expectations"QXOState Street, with EPS and revenue beating consensusINDEXES:Near midday, the Dow was down 0.05%, or 22.82, to 49,419.62, the Nasdaq was up 0.12%, or 27.82, to 23,557.84, and the S&P 500 was up 0.11%, or 7.64, to 6,952.11.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.